1.
|
|
2.
|
18 p, 1.8 MB |
Women's values and preferences on low-molecular-weight heparin and pregnancy : a mixed-methods systematic review
/
León-García, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ;
Humphries, Brittany (McMaster University (Canadà)) ;
Maraboto, Andrea (Mayo Clinic (Estats Units d'Amèrica)) ;
Rabassa Bonet, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ;
Boehmer, Kasey R. (Mayo Clinic (Estats Units d'Amèrica)) ;
Perestelo-Pérez, Lilisbeth (Servicio Canario de la Salud) ;
Xie, Feng (McMaster University (Canadà)) ;
Pelayo, Irene (Universidad de Alcalá) ;
Eckman, Mark (University of Cincinnati School of Medicine (Estats Units d'Amèrica)) ;
Bates, Shannon (McMaster University (Canadà)) ;
Selva, A (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Alonso-Coello, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Venous thromboembolism (VTE) in pregnancy is an important cause of maternal morbidity and mortality. Low-molecular-weight heparin (LMWH) is the cornerstone of prophylaxis and treatment of thrombotic events during pregnancy. [...]
2022 - 10.1186/s12884-022-05042-x
BMC Pregnancy and Childbirth, Vol. 22 (october 2022)
|
|
3.
|
11 p, 392.4 KB |
Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants
/
Corrochano, Mariana (Institut d'Investigació Biomèdica Sant Pau) ;
Acosta-Isaac, René (Institut d'Investigació Biomèdica Sant Pau) ;
Plaza, Melania (Institut d'Investigació Biomèdica Sant Pau) ;
Muñoz Diaz, Rodrigo (Intitut D'Investigacions Biomèdiques Sant Pau) ;
Mojal, Sergi (Institut d'Investigació Biomèdica Sant Pau) ;
Moret, Carla (Institut d'Investigació Biomèdica Sant Pau) ;
Souto, Joan Carles (Institut d'Investigació Biomèdica Sant Pau)
Background and purpose Renal excretion of direct oral anticoagulants (DOACs) varies depending on the drug. Hypothetically, an increased glomerular filtration rate (GFR) may lead to suboptimal dosing and a higher thromboembolic events incidence. [...]
2022 - 10.1371/journal.pone.0278693
PloS one, Vol. 17 Núm. 12 December (december 2022) , p. e0278693
|
|
4.
|
48 p, 1.4 MB |
Coating bioactive microcapsules with tannic acid enhances the phenotype of the encapsulated pluripotent stem cells
/
Choi, Daheui (Mayo Clinic, Department of Physiology and Biomedical Engineering) ;
Gwon, Kihak (Mayo Clinic. Department of Physiology and Biomedical Engineering) ;
Hong, Hye Jin (Mayo Clinic. Department of Physiology and Biomedical Engineering) ;
Baskaran, Harihara (Case Western Reserve University. Department of Chemical and Biomolecular Engineering) ;
Calvo Lozano, Olalla (Institut Català de Nanociència i Nanotecnologia) ;
Gonzalez-Suarez, Alan M. (Mayo Clinic. Department of Physiology and Biomedical Engineering) ;
Park, Kyungtae (Yonsei University. Department of Chemical and Biomolecular Engineering) ;
De Hoyos-Vega, Jose M. (Mayo Clinic. Department of Physiology and Biomedical Engineering) ;
Lechuga, Laura M (Institut Català de Nanociència i Nanotecnologia) ;
Hong, Jinkee (Yonsei University. Department of Chemical and Biomolecular Engineerin) ;
Stybayeva, Gulnaz (Mayo Clinic. Department of Physiology and Biomedical Engineering) ;
Revzin, Alexander (Mayo Clinic. Department of Physiology and Biomedical Engineering)
Human pluripotent stem cells (hPSCs) may be differentiated into any adult cell type and therefore hold incredible promise for cell therapeutics and disease modeling. There is increasing interest in three-dimensional (3D) hPSC culture because of improved differentiation outcomes and potential for scale up. [...]
2022 - 10.1021/acsami.2c06783
ACS applied materials & interfaces, Vol. 14, issue 23 (June 2022) , p. 27274-27286
|
|
5.
|
10 p, 2.6 MB |
Anticoagulant Treatment in Severe ARDS COVID-19 Patients
/
Ceccato, Adrian (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Camprubí-Rimblas, Marta (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Campaña-Duel, Elena (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Areny-Balagueró, Aina (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Morales-Quinteros, Luis (Universitat Autònoma de Barcelona. Facultat de Biociències) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Universitat Autònoma de Barcelona
Patients with COVID-19 may complicate their evolution with thromboembolic events. Incidence of thromboembolic complications are high and also, patients with the critically-ill disease showed evidence of microthrombi and microangiopathy in the lung probably due to endothelial damage by directly and indirectly injured endothelial and epithelial cells. [...]
2022 - 10.3390/jcm11102695
Journal of clinical medicine, Vol. 11 Núm. 10 (2022) , p. 2695
|
|
6.
|
|
7.
|
11 p, 2.5 MB |
Nebulised heparin as a treatment for COVID-19 : Scientific rationale and a call for randomised evidence
/
Van Haren, Frank M. P. (Intensive Care Unit. Canberra Hospital) ;
Page, Clive (Sackler Institute of Pulmonary Pharmacology. King's College London) ;
Laffey, John (Galway University Hospital) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Camprubí-Rimblas, Marta (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Nunes, Quentin (Institute of Systems. Molecular and Integrative Biology. University of Liverpool) ;
Smith, Roger (St Vincent's Hospital (Sydney)) ;
Shute, Janis (School of Pharmacy and Biomedical Science. University of Portsmouth) ;
Carroll, Mary (National Infection Service. Public Health England) ;
Tree, Julia (National Infection Service. Public Health England) ;
Carroll, Miles (National Infection Service. Public Health England) ;
Singh, Dave (Medicines Evaluation Unit. University of Manchester) ;
Wilkinson, Tom (Department of Respiratory Medicine. University of Southampton) ;
Dixon, Barry (St Vincent's Hospital (Sydney)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Nebulised unfractionated heparin (UFH) has a strong scientific and biological rationale and warrants urgent investigation of its therapeutic potential, for COVID-19-induced acute respiratory distress syndrome (ARDS). [...]
2020 - 10.1186/s13054-020-03148-2
Critical Care, Vol. 24 Núm. 1 (22 2020) , p. 454
|
|
8.
|
12 p, 775.3 KB |
Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer
/
Quintanar, Teresa (Hospital General Universitario de Elche) ;
Font, Carme (Hospital Clínic i Provincial de Barcelona) ;
Gallardo, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Barba, Raquel (Hospital Universitario Rey Juan Carlos (Madrid)) ;
Obispo, Berta (Hospital Universitario Infanta Leonor) ;
Díaz-Pedroche, Carmen (Hospital Universitario 12 de Octubre (Madrid)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Up to 20% of cancer patients will develop some manifestation of venous thromboembolic disease (VTD) during their clinical course. VTD greatly impacts morbidity, mortality, quality of life and pharmaceutical expenditure. [...]
2020 - 10.1007/s12094-020-02477-6
Clinical & Translational Oncology, Vol. 23 (september 2020) , p. 697-708
|
|
9.
|
|
10.
|
6 p, 112.0 KB |
Low-molecular-weight heparin dosage in newborn foals
/
Armengou Ruiz, Lara (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Monreal Bosch, Luis (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Delgado Jorde, M. Àngels (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Ríos, José (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Cesarini Latorre, Carlota (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
José Cunilleras, Eduard (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals)
Background: Heparin is used in humans as prophylaxis of hypercoagulable states and disseminated intravascular coagulation (DIC). However, babies need a higher heparin dose than do adults. Septic neonate foals are at high risk of hypercoagulable state and DIC, and there is limited objective information about heparin dose for equine neonates. [...]
2010 - 10.1111/j.1939-1676.2010.0568.x
Journal of Veterinary Internal Medicine, Vol. 24 (2010) , p. 1190-1195
|
|